OKYO Pharma Stock (NASDAQ:OKYO)
Previous Close
$2.65
52W Range
$0.90 - $3.35
50D Avg
$2.20
200D Avg
$1.87
Market Cap
$95.91M
Avg Vol (3M)
$151.07K
Beta
-4.46
Div Yield
-
OKYO Company Profile
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.